DHR vs QCOM: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and QUALCOMM Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
QUALCOMM Incorporated · Technology
$226.11
-10.7% upside to fair value
Grade D
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+8.9%).
QCOM trades at a lower forward P/E
(24.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
QCOM |
| Current Price |
$177.17 |
$226.11 |
| Fair Value Estimate |
$192.90 |
$201.84 |
| Upside to Fair Value |
+8.9%
|
-10.7%
|
| Market Cap |
$125.4B |
$238.3B |
| Forward P/E |
34.1x
|
24.3x
|
| EV / EBITDA |
20.8x
|
17.5x
|
| Price / Sales |
5.1x
|
5.4x
|
| Price / FCF |
23.7x
|
19.1x
|
| Revenue Growth YoY |
+3.7%
|
-3.5%
|
| Gross Margin |
60.7%
|
54.8%
|
| Operating Margin |
21.0%
|
25.5%
|
| Return on Equity |
7.1%
|
40.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
5.25%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Qualcomm Incorporated is a leading semiconductor and telecommunications equipment company specializing in cellular and RF technologies, with a strong competitive moat driven by its intellectual property and scale in premium Android and 5G modems. The company benefits from a long-tenured management team and a diversified business model expanding into automotive, IoT, and computing sectors. Despite…
Accumulation Zones
| Metric |
DHR |
QCOM |
| Zone Low |
$144.68 |
$151.38 |
| Zone High |
$163.97 |
$171.56 |
| In Buy Zone? |
No
|
No
|